| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Purified | NBP1-97007 | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| FITC | NBP1-97202 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Purified | NBP1-96776 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-63750-0.025mg | |||
![SDS-Page: Rat IgM Isotype Control [HRP] [NBP1-97203] - Lane M: 3 uL Opal Prestained Marker. Lane 1: Reduced Rat IgG Whole Molecule. Lane 2: Reduced Rat IgG F(c) Fragment. Lane 3: Reduced Rat IgG Fab Fragment. Lane 4: Reduced Rat IgM Whole Molecule Peroxidase Conjugated. Load: 1 ug of IgG, F(c), Fab; 1.5 ug of IgM.](http://images.novusbio.com/fullsize/Rat-IgM-Isotype-Control-[HRP]-SDS-Page-NBP1-97203-img0001.jpg "SDS-Page: Rat IgM Isotype Control [HRP] [NBP1-97203] - Lane M: 3 uL Opal Prestained Marker. Lane 1: Reduced Rat IgG Whole Molecule. Lane 2: Reduced Rat IgG F(c) Fragment. Lane 3: Reduced Rat IgG Fab Fragment. Lane 4: Reduced Rat IgM Whole Molecule Peroxidase Conjugated. Load: 1 ug of IgG, F(c), Fab; 1.5 ug of IgM.")
![SDS-Page: Goat IgM Isotype Control [NBP1-97008] - Lane M: 5 uL Opal Prestained Marker. Lane 1: Reduced Goat IgG Whole Molecule. Lane 2: Reduced Goat IgG F(c) Fragment. Lane 3: Reduced Goat IgG F(ab) Fragment. Lane 4: Reduced Goat IgM Whole Molecule. Load: 1 ug for IgG, F(c) and F(ab); 3 ug for IgM.](http://images.novusbio.com/fullsize/Goat-IgM-Isotype-Control-SDS-Page-NBP1-97008-img0001.jpg "SDS-Page: Goat IgM Isotype Control [NBP1-97008] - Lane M: 5 uL Opal Prestained Marker. Lane 1: Reduced Goat IgG Whole Molecule. Lane 2: Reduced Goat IgG F(c) Fragment. Lane 3: Reduced Goat IgG F(ab) Fragment. Lane 4: Reduced Goat IgM Whole Molecule. Load: 1 ug for IgG, F(c) and F(ab); 3 ug for IgM.")
![Flow Cytometry: CD45 Antibody (LT12A) [NBP2-60911] - Flow cytometry analysis using CD45 antibody (LT12A) [NBP2-60911]. Obtained with alpaca leukocytes.](http://images.novusbio.com/fullsize/CD45-Antibody-LT12A-Flow-Cytometry-NBP2-60911-img0001.jpg "Flow Cytometry: CD45 Antibody (LT12A) [NBP2-60911] - Flow cytometry analysis using CD45 antibody (LT12A) [NBP2-60911]. Obtained with alpaca leukocytes.")
![Neutralization: IL-21 Antibody (MT216G/21.3m) [NBP3-18290] - The neutralizing capacity and ND50 was determined using ELISA andELISpot. A) HEK cells were transfected to express the IL-21 activation pathway with alkaline phosphatase as a reporter. Cells were stimulated in the presence of recombinant human IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After overnight incubation, enzyme activity was measured in ELISA. B) Human peripheral blood mononuclear cells (PBMC) were incubated with recombinant IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After 4 days the IgG-secreting B cells were quantified by ELISpot.](http://images.novusbio.com/fullsize/IL-21-Antibody-MT216G-21-3m-Neutralization-NBP3-18290-img0001.jpg "Neutralization: IL-21 Antibody (MT216G/21.3m) [NBP3-18290] - The neutralizing capacity and ND50 was determined using ELISA andELISpot. A) HEK cells were transfected to express the IL-21 activation pathway with alkaline phosphatase as a reporter. Cells were stimulated in the presence of recombinant human IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After overnight incubation, enzyme activity was measured in ELISA. B) Human peripheral blood mononuclear cells (PBMC) were incubated with recombinant IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After 4 days the IgG-secreting B cells were quantified by ELISpot.")
![Flow Cytometry: CD8 Antibody (LT5A) [NBP2-60944] - Obtained with llama leukocytes](http://images.novusbio.com/fullsize/CD8-Antibody-LT5A-Flow-Cytometry-NBP2-60944-img0001.jpg "Flow Cytometry: CD8 Antibody (LT5A) [NBP2-60944] - Obtained with llama leukocytes")
![Flow Cytometry: IgM Antibody (BIG73A) [NBP2-61072] - Obtained with bovine leukocytes](http://images.novusbio.com/fullsize/IgM-Antibody-BIG73A-Flow-Cytometry-NBP2-61072-img0001.jpg "Flow Cytometry: IgM Antibody (BIG73A) [NBP2-61072] - Obtained with bovine leukocytes")
![Flow Cytometry: CD4 Antibody (GC1A) [NBP2-60890] - Obtained with caprine leukocytes](http://images.novusbio.com/fullsize/CD4-Antibody-GC1A-Flow-Cytometry-NBP2-60890-img0001.jpg "Flow Cytometry: CD4 Antibody (GC1A) [NBP2-60890] - Obtained with caprine leukocytes")
![ELISA: Recombinant Bovine IL-17/IL-17A Protein [NBP2-62444] - Bovine IL-17A ELISARecombinant Bovine IL-17Adetected using Rabbit anti Bovine IL-17A as the capture reagent and Rabbit anti Bovine IL-17A:Biotin as the detection reagent followed by Streptavidin:HRP](http://images.novusbio.com/fullsize/nbp2-62444_recombinant-bovine-il-17-il-17a-protein-23120252358479.jpg "ELISA: Recombinant Bovine IL-17/IL-17A Protein [NBP2-62444] - Bovine IL-17A ELISARecombinant Bovine IL-17Adetected using Rabbit anti Bovine IL-17A as the capture reagent and Rabbit anti Bovine IL-17A:Biotin as the detection reagent followed by Streptavidin:HRP")
![ELISA: Recombinant Rabbit IL-17/IL-17A Protein [NBP2-62449] - Rabbit Interleukin-17A ELISARecombinant Rabbit interleukin-17A detected using Chicken anti Rabbit interleukin-17A as the capture reagent and Chicken anti Rabbit interleukin-17A:Biotin as the detection reagent followed by Streptavidin:HRP](http://images.novusbio.com/fullsize/nbp2-62449_recombinant-rabbit-il-17-il-17a-protein-23120252358476.jpg "ELISA: Recombinant Rabbit IL-17/IL-17A Protein [NBP2-62449] - Rabbit Interleukin-17A ELISARecombinant Rabbit interleukin-17A detected using Chicken anti Rabbit interleukin-17A as the capture reagent and Chicken anti Rabbit interleukin-17A:Biotin as the detection reagent followed by Streptavidin:HRP")
![Western Blot: EBI3 Peptide [NBP1-76976PEP] - blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37C.](http://images.novusbio.com/fullsize/EBI3-Peptide-Western-Blot-NBP1-76976PEP-img0001.jpg "Western Blot: EBI3 Peptide [NBP1-76976PEP] - blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37C.")